No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the BCR::ABL1 Transcript Level.
Saved in:
| Title: | No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the BCR::ABL1 Transcript Level. |
|---|---|
| Authors: | Stagno, Fabio1 (AUTHOR) stagnof@unime.it, Stella, Stefania2,3 (AUTHOR), Leotta, Salvatore3,4 (AUTHOR), Caserta, Santino1,4 (AUTHOR), Vitale, Silvia Rita2,3,5 (AUTHOR), Markovic, Uros4,6 (AUTHOR), Tomarchio, Cristina1,2,3 (AUTHOR), Mirabile, Giuseppe1,2 (AUTHOR), Russo, Sabina1,3 (AUTHOR), Massimino, Michele3,4,5 (AUTHOR), Vigneri, Paolo2,5,6 (AUTHOR), Manzella, Livia2,3,6 (AUTHOR), Di Raimondo, Francesco4,5 (AUTHOR), Allegra, Alessandro1 (AUTHOR) |
| Source: | International Journal of Molecular Sciences. Mar2025, Vol. 26 Issue 5, p1840. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
